HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: A pilot study

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 5, 2012, Pages 577-583

  Asimakopoulos, Anastasios D ^a   Miano, Roberto ^a   Virgili, Guido ^a   Vespasiani, Giuseppe ^a   Finazzi Agrò, Enrico ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

High intensity focused ultrasound; Local recurrence; Prostate; Prostate cancer; Radical prostatectomy

Indexed keywords

ANTINEOPLASTIC AGENT; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG TREATMENT FAILURE; FOLLOW UP; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; MINIMALLY INVASIVE SURGERY; PELVIC FLOOR MUSCLE TRAINING; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; STRESS INCONTINENCE; TRANSRECTAL ULTRASONOGRAPHY; URETHRAL CATHETERIZATION; URINE RETENTION;

AGED; BIOPSY; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 84866764623     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.08.019     Document Type: Article

References (28)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin 1999, 49:8-31.
2. Gerber G.S., Thisted R.A., Scardino P.T., et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA 1996, 276:615-619.
3. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999, 281:1591-1597.
4. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 2008, 53:68-80.
5. Stephenson A.J., Shariat S.F., Zelefsky M.J., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004, 291:1325-1332.
6. Stephenson A.J., Scardino P.T., Kattan M.W., et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007, 25:2035-2041.
7. Chalasani V., Iansavichene A.E., Lock M., et al. Salvage radiotherapy following radical prostatectomy. Int J Urol 2009, 16:31-36.
8. Murota-Kawano A., Nakano M., Hongo S., et al. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy. BJU Int 2010, 105:1642-1645.
9. Siddiqui S.A., Mynderse L.A., Zincke H., et al. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-Gauge interstitial transperineal cryoablation: Initial experience. Urology 2007, 70:80-85.
10. Blana A., Murat F.J., Walter B., et al. First analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer. Eur Urol 2008, 53:1194-1201.
11. Murat F.J., Poissonnier L., Rabilloud M., et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 2009, 55:640-649.
12. Leventis A.K., Shariat A.F., Slawin K.M. Local recurrence after radical prostatectomy: Correlation of US features with prostatic fossa biopsy findings. Radiology 2001, 219:432-439.
13. Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg 2004, 240:205-213.
14. Blana A., Brown S.C., Chaussy C., et al. High-intensity focused ultrasound for prostate cancer: Comparative definitions of biochemical failure. BJU Int 2009, 104:1058-1062.
15. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 2008, 53:68-80.
16. Pound C.R., Partin A.W., Epstein J.I., et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy: Patterns of recurrence and cancer control. Urol Clin North Am 1997, 24:395-406.
17. MacDonald O.K., Schild S.E., Vora S., et al. Salvage radiotherapy for men with isolated rising PSA or local palpable recurrence after radical prostatectomy: Do outcomes differ?. Urology 2004, 64:760-764.
18. Rebillard X., Gelet A., Davin J.L., et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J Endourol 2005, 19:693-701.
19. Blana A., Walter B., Rogenhofer S., et al. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-Year experience. Urology 2004, 63:297-300.
20. Chaussy C., Thuroff S., Rebillard X., et al. Technology insight: High-intensity focused ultrasound for urologic cancers. Nat Clin Pract Urol 2005, 2:191-198.
21. Thuroff S., Chaussy C., Vallancien G., et al. High-intensity focused ultrasound and localized prostate cancer: Efficacy results from the European multicentric study. J Endourol 2003, 17:673-677.
22. Chapelon J.Y., Margonari J., Vernier F., et al. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res 1992, 52:6353-6357.
23. Oosterhof G.O., Cornel E.B., Smits G.A., et al. Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol 1997, 32:91-95.
24. Ward J.F., Blute M.L., Slezak J., et al. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 2003, 170:1872-1876.
25. Stephenson A.J., Scardino P.T., Kattan M.W., et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007, 25:2035-2041.
26. Choo R., Morton G., Danjoux C., et al. Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery. Radiother Oncol 2005, 74:163-167.
27. Partin A.W., Pearson J.D., Landis P.K., et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 1994, 43:649-659.
28. Patel A., Dorey F., Franklin J., et al. Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol 1997, 158:1441-1445.